题目内容
(请给出正确答案)
[单选题]
2019ASCO公布的KEYNOTE-001中帕博利珠单抗一线初治晚期NSCLC患者的5年生存率为?()
A.15.5%
B.23.2%
C.15.7%
D.12.6%
查看答案
如果结果不匹配,请 联系老师 获取答案
A.15.5%
B.23.2%
C.15.7%
D.12.6%
A.9.8%
B.13.4%
C.15.5%
D.16.7%
A.500mg
B.250mg
C.375mg
D.425mg
A.15.6个月
B.16.5个月
C.17个月
D.20.7个月
A.56%
B.49%
C.51%
D.44%